![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SEL1L3 |
Gene summary for SEL1L3 |
![]() |
Gene information | Species | Human | Gene symbol | SEL1L3 | Gene ID | 23231 |
Gene name | SEL1L family member 3 | |
Gene Alias | Sel-1L3 | |
Cytomap | 4p15.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q68CR1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23231 | SEL1L3 | HTA11_78_2000001011 | Human | Colorectum | AD | 3.82e-03 | 5.74e-01 | -0.1088 |
23231 | SEL1L3 | HTA11_347_2000001011 | Human | Colorectum | AD | 4.22e-14 | 7.43e-01 | -0.1954 |
23231 | SEL1L3 | HTA11_411_2000001011 | Human | Colorectum | SER | 1.32e-04 | 9.12e-01 | -0.2602 |
23231 | SEL1L3 | HTA11_696_2000001011 | Human | Colorectum | AD | 7.35e-05 | 4.80e-01 | -0.1464 |
23231 | SEL1L3 | HTA11_6818_2000001021 | Human | Colorectum | AD | 1.82e-03 | 5.25e-01 | 0.0588 |
23231 | SEL1L3 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 6.02e-12 | 7.30e-01 | 0.294 |
23231 | SEL1L3 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 1.91e-11 | 8.27e-01 | 0.281 |
23231 | SEL1L3 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.59e-07 | 7.08e-01 | 0.3859 |
23231 | SEL1L3 | A015-C-203 | Human | Colorectum | FAP | 2.85e-24 | -3.17e-01 | -0.1294 |
23231 | SEL1L3 | A015-C-204 | Human | Colorectum | FAP | 3.36e-06 | -2.84e-01 | -0.0228 |
23231 | SEL1L3 | A014-C-040 | Human | Colorectum | FAP | 3.24e-03 | -2.11e-01 | -0.1184 |
23231 | SEL1L3 | A002-C-201 | Human | Colorectum | FAP | 2.50e-10 | -1.47e-01 | 0.0324 |
23231 | SEL1L3 | A002-C-203 | Human | Colorectum | FAP | 1.62e-02 | 1.60e-02 | 0.2786 |
23231 | SEL1L3 | A001-C-119 | Human | Colorectum | FAP | 5.19e-04 | -1.47e-01 | -0.1557 |
23231 | SEL1L3 | A001-C-108 | Human | Colorectum | FAP | 1.94e-15 | -1.27e-01 | -0.0272 |
23231 | SEL1L3 | A002-C-205 | Human | Colorectum | FAP | 1.73e-20 | -2.11e-01 | -0.1236 |
23231 | SEL1L3 | A001-C-104 | Human | Colorectum | FAP | 6.61e-04 | 3.63e-02 | 0.0184 |
23231 | SEL1L3 | A015-C-006 | Human | Colorectum | FAP | 2.44e-13 | -2.40e-01 | -0.0994 |
23231 | SEL1L3 | A015-C-106 | Human | Colorectum | FAP | 6.76e-09 | -1.02e-01 | -0.0511 |
23231 | SEL1L3 | A002-C-114 | Human | Colorectum | FAP | 1.90e-15 | -3.26e-01 | -0.1561 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SEL1L3 | SNV | Missense_Mutation | c.1696N>A | p.Cys566Ser | p.C566S | Q68CR1 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-A2-A25F-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | taxotere | SD | |
SEL1L3 | SNV | Missense_Mutation | rs373688085 | c.698N>A | p.Arg233Gln | p.R233Q | Q68CR1 | protein_coding | tolerated(0.6) | benign(0.003) | TCGA-A8-A08B-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR |
SEL1L3 | SNV | Missense_Mutation | c.1131N>C | p.Leu377Phe | p.L377F | Q68CR1 | protein_coding | tolerated(0.14) | probably_damaging(0.965) | TCGA-A8-A09X-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
SEL1L3 | SNV | Missense_Mutation | c.2574N>C | p.Glu858Asp | p.E858D | Q68CR1 | protein_coding | deleterious(0.03) | benign(0.263) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SEL1L3 | SNV | Missense_Mutation | c.2262N>A | p.Met754Ile | p.M754I | Q68CR1 | protein_coding | deleterious(0.01) | possibly_damaging(0.843) | TCGA-AC-A5XS-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | femara | SD | |
SEL1L3 | SNV | Missense_Mutation | c.806N>T | p.Arg269Met | p.R269M | Q68CR1 | protein_coding | deleterious(0.05) | benign(0.312) | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SEL1L3 | SNV | Missense_Mutation | novel | c.2146N>C | p.Trp716Arg | p.W716R | Q68CR1 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-B6-A0IK-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
SEL1L3 | SNV | Missense_Mutation | novel | c.2716N>C | p.Glu906Gln | p.E906Q | Q68CR1 | protein_coding | tolerated(0.07) | probably_damaging(0.972) | TCGA-BH-A0B6-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SEL1L3 | SNV | Missense_Mutation | novel | c.1240T>G | p.Phe414Val | p.F414V | Q68CR1 | protein_coding | deleterious(0) | possibly_damaging(0.776) | TCGA-BH-A1FH-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
SEL1L3 | SNV | Missense_Mutation | c.1654C>T | p.His552Tyr | p.H552Y | Q68CR1 | protein_coding | tolerated(0.11) | benign(0.081) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |